1 材料与方法
1.1 数据库
1.2 苦豆子活性成分的筛选与获取
1.3 苦豆子潜在有效活性成分相关靶点的获取
1.4 热应激相关靶点的筛选与获取
1.5 蛋白质-蛋白质相互作用(PPI)网络构建及核心靶点筛选
1.6 基因本体(GO)功能富集分析和京都基因与基因组百科全书数据库(KEGG)通路富集分析
1.7 苦豆子-潜在有效活性成分-热应激靶点-信号通路网络图构建
1.8 分子对接验证
2 结果与分析
2.1 苦豆子的潜在有效活性成分靶点分析
表1 苦豆子的潜在有效活性成分Table 1 Potential effective active ingredients in Sophora alopecuroides L. |
| 分子编号 Molecular No. | 分子名称 Molecular name | 口服生物利用度 OB/% | 分子质量 MW/u | SMILES表达式 SMILES expression |
|---|---|---|---|---|
| MOL006570 | (-)-9α-羟基槐胺碱 (-)-9alpha-hydroxysophoramine | 35.226 54 | 262.39 | C1CC2CN3C(CC=CC3=O) C4C2N(C1)CC(C4)O |
| MOL005945 | 金雀花碱 Cytisine | 69.400 08 | 190.24 | C1C2CNCC1C3=CC=CC (=O)N3C2 |
| MOL012952 | 无刺枣碱A Daechualkaloid A | 34.937 35 | 179.22 | C1CC2N(C1)C3= C(CCC3=O)CO2 |
| MOL005944 | 苦参碱 Matrine | 63.774 93 | 248.36 | C1CC2C3CCCN4C3C(CCC4) CN2C(=O)C1 |
| MOL000421 | 尼克酸 Nicotinic acid | 47.645 29 | 123.11 | C1=CC(=CN=C1)C(=O)O |
| MOL003632 | N-甲基金雀花碱 N-methylcytisine | 76.704 35 | 204.27 | CN1CC2CC(C1)C3= CC=CC(=O)N3C2 |
| MOL003633 | 羟基那可汀 Oxynarcotine | 56.742 70 | 431.40 | CNCCC1=CC2=C(C(=C1CC(=O) C3=C(C(=C(C=C3)OC)OC)C (=O)O)OC)OCO2 |
| MOL003627 | 槐果碱 Sophocarpine | 64.264 33 | 246.35 | C1CC2CN3C(CC=CC3=O) C4C2N(C1)CCC4 |
| MOL003676 | 槐胺碱 Sophoramine | 42.161 88 | 244.33 | C1CC2CN3C(=O)C=CC= C3C4C2N(C1)CCC4 |
| MOL003680 | 槐定碱Sophoridine | 60.070 33 | 248.36 | C1CC2C3CCCN4C3C(CCC4) CN2C(=O)C1 |
2.2 苦豆子-潜在有效活性成分-作用靶点网络图构建
图1 苦豆子-潜在有效活性成分-作用靶点网络图仅注释度值排名前50的节点 Only the top 50 nodes ranked by annotation degree values。Sophoramine:槐胺碱;Sophocarpine:槐果碱;Cytisine:金雀花碱;(-)-9alpha-hydroxysophoramine:(-)-9α-羟基槐胺碱;Sophoridine:槐定碱;Oxynarcotine:羟基那可汀Oxynarcotine: Hydroxynarcotine;N-methylcytisine:N-甲基金雀花碱;Matrine:苦参碱;Daechualkaloid A:无刺枣碱A;Nicotinic acid:尼克酸;SRD5A2:5α-还原酶 2 steroid 5-alpha-reductase 2;PARP1:多聚ADP核糖聚合酶1 poly ADP-ribose polymerase 1;CHRNA4:烟碱型乙酰胆碱受体α4亚基 cholinergic receptor nicotinic alpha 4 subunit;CHRNB2:烟碱型乙酰胆碱受体β2亚基 cholinergic receptor nicotinic beta 2 subunit;ROCK2:Rho相关蛋白激酶2 Rho-associated coiled-coil containing protein kinase 2;HTR3A:5-羟色胺3A受体 5-hydroxytryptamine receptor 3A;SLC6A3:多巴胺转运体 solute carrier family 6 member 3;CHRM2:毒蕈碱型乙酰胆碱受体 M2 cholinergic receptor muscarinic 2;CYP19A1:芳香化酶 cytochrome P450 family 19 subfamily A member 1;BRD4:溴结构域蛋白4 bromodomain containing 4;JAK2:Janus激酶2 Janus kinase 2;ESR2:雌激素受体β estrogen receptor 2;HTR2B:5-羟色胺2B受体 5-hydroxytryptamine receptor 2B;DPP9:二肽基肽酶9 dipeptidyl peptidase 9;HTR1F:5-羟色胺1F受体 5-hydroxytryptamine receptor 1F;ROCK1:Rho相关蛋白激酶1 Rho-associated coiled-coil containing protein kinase 1;DRD1:多巴胺D1受体 dopamine receptor D1;CHRM5:毒蕈碱型乙酰胆碱受体M5 cholinergic receptor muscarinic 5;CHRM4:毒蕈碱型乙酰胆碱受体M4 cholinergic receptor muscarinic 4;CHRM3:毒蕈碱型乙酰胆碱受体M3 cholinergic receptor muscarinic 3;PDE7A:磷酸二酯酶7A phosphodiesterase 7A;MALT1:黏膜相关淋巴组织淋巴瘤转运蛋白1 mucosa associated lymphoid tissue lymphoma translocation protein 1;PRMT3:蛋白质精氨酸甲基转移酶3 protein arginine methyltransferase 3;TYK2:酪氨酸激酶2 tyrosine kinase 2;JAK3:Janus激酶3 Janus kinase 3;PBK:PDZ结合激酶 PDZ binding kinase;PIM2:丝氨酸/苏氨酸激酶PIM2 pim-2 proto-oncogene, serine/threonine kinase;PARP2:多聚ADP核糖聚合酶2 poly ADP-ribose polymerase 2;CHRNA7:烟碱型乙酰胆碱受体α7亚基 cholinergic receptor nicotinic alpha 7 subunit;SRD5A1:5α-还原酶1 steroid 5-alpha-reductase 1;DRD5:多巴胺D5受体 dopamine receptor D5;TACR1:速激肽1受体 tachykinin receptor 1;DPP8:二肽基肽酶 8 dipeptidyl peptidase 8;JAK1:Janus激酶1 Janus kinase 1;ADRA2B:α2B肾上腺素能受体 adrenoceptor alpha 2B;DRD2:多巴胺D2受体 dopamine receptor D2;SLC6A4:5-羟色胺转运体 solute carrier family 6 member 4;CHRNA3:烟碱型乙酰胆碱受体α3亚基 cholinergic receptor nicotinic alpha 3 subunit;CHRNB4:烟碱型乙酰胆碱受体β4亚基 cholinergic receptor nicotinic beta 4 subunit;HSP90AA1:热休克蛋白90αA1 heat shock protein 90 alpha family class A member 1。 Fig.1 Network diagram of Sophora alopecuroides L.-potential effective active ingredients-targets of action |
2.3 热应激相关靶点分析
2.4 苦豆子潜在有效活性成分作用靶点与热应激相关靶点的交集靶点分析
2.5 苦豆子治疗热应激潜在作用靶点的PPI网络构建
图4 可视化PPI网络图网络中节点越大、颜色越深代表度值越大,该节点在该网络中越重要 The larger the node in the network, the darker the color, and the larger the degree value, the more important the node is in the network。仅注释图中关键节点 Annotate only the key nodes in the diagram。AKT1:蛋白激酶B1 protein kinase B1;CASP3:半胱氨酸天冬氨酸蛋白酶3 caspase 3;EGFR:表皮生长因子受体 epidermal growth factor receptor;HSP90AA1:热休克蛋白90αA1 heat shock protein 90 alpha family class A member 1;MMP9:基质金属蛋白酶9 matrix metalloproteinase 9;PTGS2:前列腺素内过氧化物合酶2 prostaglandin-endoperoxide synthase 2;GSK3B:糖原合成酶激酶3β glycogen synthase kinase 3 beta;APP:淀粉样前体蛋白 amyloid precursor protein;TLR4:Toll样受体4 Toll-like receptor 4;ERBB2:人表皮生长因子受体2 Erb-b2 receptor tyrosine kinase 2;MDM2:鼠双微体2 蛋白 mouse double minute 2 homolog;PARP1:多聚ADP核糖聚合酶1 poly (ADP-ribose) polymerase 1;ACE:血管紧张素转换酶 angiotensin-converting enzyme;CDK2:细胞周期蛋白依赖性激酶2 cyclin-dependent kinase 2;MMP2:基质金属蛋白酶2 matrix metalloproteinase 2;KDR:血管内皮生长因子受体2 kinase insert domain receptor;CDC42:细胞分裂周期蛋白42 cell division cycle 42;HDAC1:组蛋白去乙酰化酶1 histone deacetylase 1;JAK2:Janus激酶2 Janus kinase 2;MAOA:单胺氧化酶A monoamine oxidase A;PTPRC:蛋白酪氨酸磷酸酶受体C protein tyrosine phosphatase receptor type C;MAOB:单胺氧化酶B monoamine oxidase B;CDK1:细胞周期蛋白依赖性激酶1 cyclin-dependent kinase 1;PIK3CA:磷脂酰肌醇3-激酶催化亚基α phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;CTSB:组织蛋白酶B cathepsin B;CCNA2:细胞周期蛋白A2 cyclin A2;NR3C1:核受体亚家族3C成员1 nuclear receptor subfamily 3 group C member 1;MCL1:髓细胞白血病1蛋白 myeloid cell leukemia 1;MAPK14:丝裂原活化蛋白激酶14 mitogen-activated protein kinase 14;ITGB1:整合素β1 integrin beta 1;DRD2:多巴胺D2受体 dopamine receptor D2;CHEK1:细胞周期检测点激酶1 checkpoint kinase 1;ABL1:ABL原癌基因1 ABL proto-oncogene 1;AR:雄激素受体 androgen receptor。 Fig.4 Visualized PPI network diagram |
2.6 GO功能富集分析与KEGG通路富集分析
图5 GO功能富集分析图Biological process:生物过程;Cellular component:细胞组分;Molecular function:分子功能;positive regulation of MAPK cascade:丝裂原活化蛋白激酶级联的正向调控;response to xenobiotic stimulus:对异生物质刺激的反应;protein phosphorylation:蛋白质磷酸化;chemical synaptic transmission:化学突触传递;adenylate cyclase-activating adrenergic receptor signaling pathway:腺苷酸环化酶激活的肾上腺素能受体信号通路;G protein-coupled receptor signaling pathway;coupled to cyclic nucleotide second messenger:与环核苷酸第2信使偶联的G蛋白偶联受体信号通路;proteolysis:蛋白质水解;cellular response to amyloid-beta:细胞对淀粉样β的应答;peptidyl-serine phosphorylation:肽基丝氨酸磷酸化;intracellular signal transduction:细胞内信号转导;plasma membrane:质膜;synapse:突触;cell surface:细胞表面;dendrite:树突;postsynaptic membrane:突触后膜;membrane raft:膜筏;presynaptic membrane:突触前膜;cytoplasm:细胞质;neuronal cell body:神经元胞体;protein-containing complex:含蛋白质的复合物;identical protein binding:相同蛋白质结合;protein kinase activity:蛋白激酶活性;protein serine/threonine kinase activity:蛋白质丝氨酸/苏氨酸激酶活性;histone H3Y41 kinase activity:组蛋白H3Y41激酶活性;histone H2AXY142 kinase activity:组蛋白H2AXY142激酶活性;enzyme binding:酶结合;protein serine kinase activity:蛋白质丝氨酸激酶活性;protein tyrosine kinase activity:蛋白质酪氨酸激酶活性;ATP binding:ATP结合;endopeptidase activity:内肽酶活性。 Fig.5 GO functional enrichment analysis chart |
图6 KEGG通路富集分析图Neuroactive ligand-receptor interaction:神经活性配体-受体相互作用;Calcium signaling pathway:钙信号通路;Proteoglycans in cancer:癌症中的蛋白聚糖;Serotonergic synapse:血清素能突触;Pathways in cancer:癌症中的通路;Focal adhesion:黏着斑;Prostate cancer:前列腺癌;PI3K-Akt signaling pathway:磷脂酰肌醇3激酶-蛋白激酶B信号通路;Dopaminergic synapse:多巴胺能突触;Apoptosis:细胞凋亡;Lipid and atherosclerosis:脂质与动脉粥样硬化;Endocrine resistance:内分泌抵抗;Fluid shear stress and atherosclerosis:流体剪切应力与动脉粥样硬化;cAMP signaling pathway:环磷酸腺苷信号通路;cGMP-PKG signaling pathway:环鸟苷酸依赖性蛋白激酶信号通路;Insulin resistance:胰岛素抵抗;VEGF signaling pathway:血管内皮生长因子信号通路;AGE-RAGE signaling pathway in diabetic complications:糖尿病并发症中的AGE-RAGE信号通路;Chemical carcinogenesis-receptor activation:化学致癌作用-受体激活;Neurotrophin signaling pathway:神经营养因子信号通路。图7同 the same as Fig.7。 Fig.6 KEGG pathway enrichment analysis chart |
2.7 苦豆子-潜在有效活性成分-热应激靶点-信号通路网络图构建
2.8 分子对接验证结果
表2 苦豆子潜在有效活性成分与核心靶点的结合能力Table 2 Binding ability of active ingredients in Sophora alopecuroides L. and core targets |
| 序号 Serial number | 配体 Ligand | 受体 Receptor | PDB数据库编号 PDB database ID | 结合能 Binding energy/ (kJ/mol) |
|---|---|---|---|---|
| A | (-)-9α-羟基槐胺碱 (-)-9alpha-hydroxysophoramine | 蛋白激酶B1 AKT1 | 5AAR | -28.70 |
| B | 金雀花碱 Cytisine | 蛋白激酶B1 AKT1 | 5AAR | -27.41 |
| C | 表皮生长因子受体 EGFR | 6TFV | -24.39 | |
| D | 无刺枣碱A Daechualkaloid A | 表皮生长因子受体 EGFR | 6TFV | -26.86 |
| E | 苦参碱 Matrine | 热休克蛋白90αA1 HSP90AA1 | 7S8Y | -35.06 |
| F | 尼克酸 Nicotinic acid | 热休克蛋白90αA1 HSP90AA1 | 7S8Y | -25.06 |
| G | N-甲基金雀花碱 N-methylcytisine | 半胱氨酸天冬氨酸蛋白酶3 CASP3 | 1RHJ | -24.52 |
| H | 表皮生长因子受体 EGFR | 6TFV | -24.31 | |
| I | 羟基那可汀Oxynarcotine | 表皮生长因子受体 EGFR | 6TFV | -28.45 |
| J | 基质金属蛋白酶9 MMP9 | 5UE4 | -21.55 | |
| K | 槐果碱 Sophocarpine | 热休克蛋白90αA1 HSP90AA1 | 7S8Y | -35.56 |
| L | 槐胺碱 Sophoramine | 热休克蛋白90αA1 HSP90AA1 | 7S8Y | -33.64 |
| M | 槐定碱Sophoridine | 热休克蛋白90αA1 HSP90AA1 | 7S8Y | -35.15 |

京公网安备 11010802041926号